首页> 外文OA文献 >Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development

【2h】

Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development

机译：卵巢透明细胞腺纤维瘤，非典型增生性（边界线）肿瘤和癌的发病机制：子宫内膜异位或腺纤维瘤成分的肿瘤的临床病理特征支持肿瘤发展的两种相关途径

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Zhao, Chengquan; Wu, Lee Shu-Fune; Barner, Ross;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development [J] . Chengquan Zhao, Lee Shu-Fune Wu, Ross Barner Journal of Cancer . 2011,第1期

机译：卵巢透明细胞腺纤维瘤，非典型增生性（边界线）肿瘤和癌的发病机制：子宫内膜异位或腺纤维瘤成分的肿瘤的临床病理特征支持肿瘤发展的两种相关途径
2. BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors (vol 38, pg 1603, 2014) [J] . Zeppernick F., Ardighieri L., Hannibal C. American Journal of Surgical Pathology . 2015,第7期

机译：BRAF突变与特定细胞类型相关，其特征提示卵巢浆液性交界性（非典型增生性）肿瘤衰老（第38卷，第1603页，2014年）
3. BRAF Mutation Is Associated With a Specific Cell Type With Features Suggestive of Senescence in Ovarian Serous Borderline (Atypical Proliferative) Tumors [J] . Zeppernick Felix, Ardighieri Laura, Hannibal Charlotte G., American Journal of Surgical Pathology . 2014,第12期

机译：BRAF突变与特定类型的细胞相关，其特征提示卵巢浆液性交界性（非典型增生）肿瘤的衰老。
4. Ultrasound-Triggered Targeting of Micellar Drug Carriers to Ovarian Carcinoma Tumors In Vivo [C] . Controlled Release Society annual meeting . 2004

机译：超声触发胶束药物载体对体内卵巢癌肿瘤的靶向
5. The development of intratumoral heterogeneity in ovarian tumors: Role of cancer stem cells in disease progression. [D] . Lunsford, Elaine P. 2014

机译：卵巢肿瘤内肿瘤异质性的发展：癌症干细胞在疾病进展中的作用。
6. Pathogenesis of Ovarian Clear Cell Adenofibroma Atypical Proliferative (Borderline) Tumor and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development [O] . Chengquan Zhao, Lee Shu-Fune Wu, Ross Barner 2011

机译：卵巢透明细胞腺纤维瘤非典型增生性（边界线）肿瘤和癌的发病机制：子宫内膜异位或腺纤维瘤成分的肿瘤的临床病理特征支持肿瘤发展的两种相关途径
7. Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor with Intraepithelial Carcinoma [O] . 2020

机译：边缘线卵巢透明细胞肿瘤/非典型增殖卵巢透明细胞肿瘤与上皮内癌
8. Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 1 - Molecular Characterization of Ovarian Serous Tumors Developing Along Different Pathways [R] . Kurman, R. J. , Shih, I. 2003

机译：卵巢浆液性癌的发病机制是免疫定向诊断和治疗的基础。项目1 - 沿不同途径发展的卵巢浆液性肿瘤的分子特征

Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development

著录项

相似文献

相关主题

期刊订阅